Connor, Clark & Lunn Investment Management (CC&L)’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,409
| Closed | -$326K | – | 1567 |
|
|
2024
Q2 | $326K | Sell |
7,409
-17,717
| -71% | -$779K | ﹤0.01% | 1164 |
|
|
2024
Q1 | $1.26M | Buy |
25,126
+7,890
| +46% | +$396K | 0.01% | 812 |
|
|
2023
Q4 | $1.04M | Buy |
+17,236
| New | +$1.04M | ﹤0.01% | 852 |
|
|
2023
Q3 | – | Sell |
-9,421
| Closed | -$480K | – | 1468 |
|
|
2023
Q2 | $480K | Buy |
+9,421
| New | +$480K | ﹤0.01% | 991 |
|